Patrice Guillon Selected Research

HN Protein

1/2017	Exploring inhibitor structural features required to engage the 216-loop of human parainfluenza virus type-3 hemagglutinin-neuraminidase.
3/2015	The catalytic mechanism of human parainfluenza virus type 3 haemagglutinin-neuraminidase revealed.
9/2014	Exploring human parainfluenza virus type-1 hemagglutinin-neuraminidase as a target for inhibitor discovery.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Patrice Guillon Research Topics

Disease

8	Infections 01/2021 - 04/2006
8	Paramyxoviridae Infections (Parainfluenza) 01/2019 - 09/2014
3	Virus Diseases (Viral Diseases) 01/2017 - 09/2014
2	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2017 - 03/2015
1	COVID-19 01/2021

Drug/Important Bio-Agent (IBA)

8	VaccinesIBA 01/2019 - 09/2014
7	Neuraminidase (Sialidase)IBA 01/2019 - 09/2014
5	Pharmaceutical PreparationsIBA 01/2021 - 09/2014
3	Antiviral Agents (Antivirals)IBA 01/2019 - 10/2014
3	HN ProteinIBA 01/2017 - 09/2014
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 09/2014
2	Hemagglutinins (Hemagglutinin)IBA 01/2017 - 09/2014
2	Suramin (Suramin Sodium)IBA 04/2016 - 09/2014
2	Blood Group Antigens (Blood Groups)IBA 01/2010 - 12/2008
1	SARS-CoV-2 spike proteinIBA 01/2021
1	lumacaftorIBA 01/2021
1	lifitegrastIBA 01/2021
1	Angiotensin-Converting Enzyme 2IBA 01/2021
1	Evans Blue (Blue, Evans)FDA Link 01/2021
1	SodiumIBA 01/2021
1	Drug CombinationsIBA 04/2016
1	Zanamivir (Relenza)FDA Link 04/2016
1	AcidsIBA 09/2014
1	2-deoxy-2,3-dehydro-N-acetylneuraminic acidIBA 09/2014
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 09/2014
1	Galactoside 2-alpha-L-fucosyltransferase (Fucosyltransferase 2)IBA 01/2010
1	EnzymesIBA 01/2010
1	OligodeoxyribonucleotidesIBA 04/2006
1	Cholera ToxinIBA 04/2006

Therapy/Procedure

2	Therapeutics 01/2021 - 04/2016